Evidence map›Paper›PMID 29659614›Full record

ArticlePLoS pathogens2018

KSHV induces immunoglobulin rearrangements in mature B lymphocytes.

Jennifer Totonchy, Jessica M Osborn, Amy Chadburn, Ramina Nabiee, Lissenya Argueta, Geoffrey Mikita, Ethel Cesarman

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. A Critical Role for Epstein-Barr Virus in Primary Effusion Lymphoma.Current topics in microbiology and immunology · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Immunotherapy for KSHV-associated diseases.Current opinion in virology · 2022
    Review
  9. Article
  10. Review
  11. Castleman disease.Nature reviews. Disease primers · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jennifer TotonchyPathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, United States of Amercia.ORCID 0000-0002-8444-8536
Jessica M OsbornPathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, United States of Amercia.ORCID 0000-0003-1242-4962
Amy ChadburnPathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, United States of Amercia.ORCID 0000-0002-9499-8638
Ramina NabieeBiomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, CA, United States of Amercia.
Lissenya ArguetaPathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, United States of Amercia.
Geoffrey MikitaPathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, United States of Amercia.
Ethel CesarmanPathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, United States of Amercia.
Cornell University · USChapman University · US

Funding

Modeling KSHV latency in vivoR01CA103646 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CESARMAN, ETHEL · 2004 to 2016
$3.5M
Targeting vFLIP for the treatment of KSHV-associated malignanciesR01CA154228 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CESARMAN, ETHEL · 2011 to 2015
$1.7M
Factors Influencing KSHV Infection and Spread within the Oral CavityR00DE024969 · NIDCR · CHAPMAN UNIVERSITY · PI TOTONCHY, JENNIFER E · 2017 to 2019
$747k
Factors Influencing KSHV Infection and Spread within the Oral CavityK99DE024969 · NIDCR · WEILL MEDICAL COLL OF CORNELL UNIV · PI TOTONCHY, JENNIFER E · 2015 to 2016
$246k
NCI NIH HHS R01 CA103646NCI NIH HHS R01 CA154228NIDCR NIH HHS K99 DE024969NIDCR NIH HHS R00 DE024969NIH HHS 1R01CA154228NIH HHS 5K99 DE024969-01NIH HHS R01-CA103646
6 · The paper itself

Abstract

Kaposi sarcoma herpesvirus (KSHV/HHV-8) is a B cell tropic human pathogen, which is present in vivo in monotypic immunoglobulin λ (Igλ) light chain but polyclonal B cells. In the current study, we use cell sorting to infect specific B cell lineages from human tonsil specimens in order to examine the immunophenotypic alterations associated with KSHV infection. We describe IL-6 dependent maturation of naïve B lymphocytes in response to KSHV infection and determine that the Igλ monotypic bias of KSHV infection in vivo is due to viral induction of BCR revision. Infection of immunoglobulin κ (Igκ) naïve B cells induces expression of Igλ and isotypic inclusion, with eventual loss of Igκ. We show that this phenotypic shift occurs via re-induction of Rag-mediated V(D)J recombination. These data explain the selective presence of KSHV in Igλ B cells in vivo and provide the first evidence that a human pathogen can manipulate the molecular mechanisms responsible for immunoglobulin diversity.

Indexed as

Gene RearrangementB-LymphocytesCells, CulturedHerpesviridae InfectionsHerpesvirus 8, HumanHumansImmunoglobulin lambda-ChainsImmunoglobulin lambda-Chains

Identifiers

PMID29659614
PMCPMC5919685
OpenAlexW2802237436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.